OrCam

AI & Data Platforms Founded 2010

Last updated: Jul 31, 2026

OrCam Technologies develops AI-enabled wearable and handheld assistive devices that convert visual information into spoken output for people who are blind, have low vision, or experience reading difficulties. Its public product portfolio centers on OrCam MyEye and OrCam Read, while recent reporting indicates a major downsizing and a pivot toward hearing technology.

Visit Website

Company Overview

OrCam is a Jerusalem-based assistive-technology company founded in 2010 by Mobileye co-founders Amnon Shashua and Ziv Aviram. Its best-known products put a camera, onboard processing, controls, and audio output into a wearable or handheld device. OrCam MyEye is designed to attach to glasses and interpret selected text and visual cues for users who are blind or visually impaired; OrCam Read is a handheld reader for printed or digital text and for reading challenges such as dyslexia or reading fatigue. The official product and FAQ pages describe text reading, face and product recognition, currency and color recognition, voice activation, and operation without a continuous internet connection. Those capabilities make the company a concrete example of edge computer vision packaged around a narrow, high-value human need rather than a general-purpose AI application.

The technical proposition combines camera capture, optical character recognition, visual classification, face and product recognition, language selection, speech synthesis, and a low-friction human-machine interface. The dedicated form factor can provide predictable controls and audio feedback for users who cannot comfortably operate a smartphone, and offline operation can improve privacy and availability in settings with poor connectivity. The tradeoff is that the device must work reliably across lighting, print quality, languages, accents, user movement, and diverse real-world environments. It also requires a user who can aim the camera or move a handheld unit and hear the output. These constraints make validation, usability, multilingual support, battery life, servicing, and training at least as important as benchmark model accuracy.

The commercial market is specialized and distribution is likely to be more complicated than a normal consumer software sale. Customers and influencers can include individuals and families, schools, employers, clinicians, disability organizations, distributors, and public or insurance-assisted purchasing programs. OrCam states that it sells in multiple countries and supports many languages, while its FAQ describes payment plans and location-dependent financial assistance. At the same time, the category faces substitution from increasingly capable smartphone accessibility features, free apps such as Seeing AI and Lookout, human-assistance services such as Be My Eyes and Aira, and lower-cost magnification or reading tools. A premium purpose-built device can win on simplicity, privacy, offline use, and specialized workflow, but it must justify hardware cost and ongoing support against rapidly improving general-purpose AI.

The current company condition needs more weight than the earlier growth narrative. LinkedIn presents OrCam as a privately held Jerusalem company founded in 2010 and shows roughly 170 listed employees, while 2025 reporting from CTech and Globes described a much larger contraction, layoffs, investor disputes, pressure for bridge financing, and a pivot from vision products toward hearing aids. The official website still provides active product, support, and research material for MyEye and Read, so the database should not treat the product pages alone as proof of current sales, headcount, profitability, or product-development continuity. The most important diligence questions are whether vision-device inventory and support remain active in each market, whether the hearing product has reached commercial launch, what capital structure and runway remain after the restructuring, and whether the reported headcount is current.

Defense and national-security relevance is limited and indirect. Wearable visual assistance, OCR, edge inference, audio interfaces, and offline processing could inform accessibility for personnel, field inspection, logistics, training, or degraded-connectivity support. However, the public evidence does not establish defense customers, military contracts, secure deployment, ruggedization, or mission-critical performance. The appropriate classification is therefore a civilian assistive-technology company with a modest dual-use adjacency, not a defense technology supplier. Its strategic value is greater as a case study in edge AI productization, privacy-sensitive perception, and accessible human-machine interaction than as a direct Claw & Talon target.

Strategic Fit Assessment

OrCam has credible applied computer-vision heritage and a socially important product category, but the current evidence points to restructuring, material headcount reduction, financing pressure, and a strategic pivot. Its civilian market remains differentiated by dedicated hardware and offline use, yet the business is not a clear priority signal for a defense-oriented deep-tech screen and this flag is not an investment recommendation.

Strategic Value to U.S.-Israel Alliance

Strategic value is moderate as an Israeli edge-AI and accessibility case study, but low as a direct defense or security asset. The relevant lessons concern productizing perception on constrained hardware, designing audio-first interfaces, and managing privacy and reliability in assistive systems. Any strategic assessment should first confirm whether the vision portfolio is still supported and whether the hearing pivot has viable commercialization.

Key Technologies

  • On-device computer vision for wearable and handheld cameras
  • Optical character recognition for printed and digital text
  • Face, product, barcode, currency, and color recognition
  • Voice activation and targeted text-selection interfaces
  • Offline edge inference and privacy-preserving local processing
  • Multilingual text-to-speech and audio feedback
  • Assistive human-machine interaction for users with visual or reading disabilities

Use Cases & Applications

  • Reading books, mail, menus, forms, labels, screens, and street signs for blind or low-vision users
  • Identifying familiar people, consumer products, barcodes, colors, and paper currency
  • Selecting and reading only a relevant passage from a page or document
  • Supporting students and workers with dyslexia, reading fatigue, or mild low vision
  • Private offline visual assistance in homes, workplaces, schools, and public spaces
  • Field inspection or logistics support where hands-free audio access to text is useful
  • Accessibility support for personnel operating in noisy, mobile, or intermittently connected environments

Sources and verification

This profile is based on public-source research, Claw & Talon curation, and editorial judgment. Inclusion does not imply endorsement, partnership, investment, or a recommendation to transact. Readers should still confirm current status, customers, funding, and product claims before relying on this profile. The editorial policy explains how profiles are researched, where automated drafting is used, and how corrections work.

This record lists 9 public references used for company identity, status, positioning, or material-claim review.

Public sources

The links below are visible public references used for source discipline around company identity, status, funding, customer, acquisition, public-company, or other material claims where available.

Investor Lens

What this entry is

Private startup

Why it may matter

OrCam may matter as a AI & Data Platforms entry with not currently an investable standalone company for Israeli technology research.

How an independent investor should read this

Not currently an investable standalone company. Read this profile as a starting point for independent verification, not as a recommendation or suitability assessment.

Evidence to verify

  • Verify current status
  • Verify traction
  • Verify cap table/funding
  • Verify technical claims
  • Verify customer concentration

Main investor questions

  • Is the company currently active, independently financeable, and raising or not raising on terms you can verify?
  • What customer, revenue, product, and technical evidence supports the company story?
  • What valuation, cap table, rights, and follow-on assumptions would govern any private exposure?
  • What evidence would change the thesis or show that the profile is stale?

What not to infer

  • Inclusion does not imply endorsement.
  • Inclusion does not imply allocation availability or current fundraising.
  • Scores do not indicate investment suitability or expected returns.
  • Strategic importance does not automatically imply venture return potential.

Diligence questions

  • What evidence verifies OrCam's current customer traction, deployment status, and revenue concentration?
  • Which technical claims are independently demonstrable today, and which remain roadmap or pilot-stage assertions?
  • Is there a credible national-security or public-sector use case, or is the company primarily a commercial technology asset?
  • What data rights, model-evaluation, compute, and reliability constraints determine whether the system can operate in mission-critical settings?
  • Is the company a live venture opportunity, a mature strategic reference, an acquired asset, or primarily a market-mapping entry?

Related sector

See the AI & Data Platforms sector page for market context, related subcategories, and other Israeli companies in this part of the database.

Need a diligence readout?

Use the profile and related checklists as a starting point. If the decision needs more context, request a company screen, founder-call prep, diligence memo, or sector readout.